In Play

About Us

The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

Investor Tools

We Buy Penny Stocks
Market Movers
Caveat Emptor Status Changes
Cryptocurrency Center

Public Companies

Emerging Growth Investor Relations
Brand Ambassador & Talent

Presenter Testimonials
Conference Highlights

© Copyright 2009-2026 - EmergingGrowth.com -- Images via Shutterstock -- Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. Data delayed 15 minutes unless indicated. Electronic EG content as further described in our disclosure (link on the bottom of every page) is for informational purposes only and does not reflect the opinions of EmergingGrowth.com or any of its affiliates. All viewers of EmergingGrowth.com content a. understand and agree that such content does not represent trading or investment advice, and b. agree that they will not hold EmergingGrowth.com or any of its affiliates or subsidiaries liable for any loss or damage caused by your reliance on information contained within.

In Play

CytoDyn Update Reveals Q1 Sales Pipeline, Philippine EUA, NASDAQ Uplisting, & High Likelihood of Approval

Cracking the FDA Code to COVID-19 Approvals

Misleading Headline on CydoDyn (CYDY) Triggers Algo Selling

STAT News’ Adam Feuerstein Uses Up His Nine Lives on CytoDyn (OTCQB: CYDY)

CytoDyn’s (CYDY) 100% Above Market Offering Stuns the Street

Why VBI Vaccines (NASDAQ: VBIV) Could Be a Contrarian Investor’s Dream

Galectin Therapeutics (GALT) is Due for a COVID-19 Makeover

Kaival Brands (KAVL) Where There’s Smoke There’s Fire

The Public Companies Leading the Digital Transformation in the Way We...

Tonix Pharmaceuticals (TNXP) Could Be a Come-From-Behind Vaccine Shocker

Hottest Energy Disrupter Stock of 2020?

Filecoin Could Be the Ultimate Disrupter

Post-Pandemic Investment Ideas Like iQSTEL (IQST) Sometime Start out in Small...

Gilead Acquisition of CymaBay Rekindles Interest in Liver Disease

MOST POPULAR

ZenaTech (NASDAQ: ZENA) Reports Record 558% Year-Over-Year Revenue Growth to $12.9...

SBC Medical Group Holdings, Inc. (NASDAQ: SBC) Emerging Growth Research Report...

Immuron Limited (NASDAQ: IMRN) (ASX: IMC) Emerging Growth Research Report –...

ZenaTech (NASDAQ: ZENA) Continues International Expansion Opening New Offices in South...

About Us

Directory

Investor Tools

Public Companies